The number of people living with companion animals has been increasing annually worldwide. According to the 2013 to 2014 American Pet Products Association survey, about 70% of U.S. households include companion animals \[[@r20]\]. In the Korean pet industry, the market size associated with companion animals is rapidly increasing and estimated to be \$5.4 billion by 2020 \[[@r27]\]. Additionally, most owners consider their pets as family members and go to great lengths for their medical treatment \[[@r32]\]. As such, the use of antimicrobials in pets is increasing, which has resulted in the emergence and spread of antimicrobial-resistant (AR) bacteria. Companion animals are often considered as one of the reservoirs of AR bacteria that could be transferrable to their owners through direct or indirect contact \[[@r2], [@r25]\]. Direct contact includes a bite, lick or scratch and handling of animal feces, whereas indirect contact can occur by sharing the bed or toilet environment or being bitten by arthropods originating from pets \[[@r24]\].

AR bacteria in companion animals can be cross-transmitted to humans \[[@r2], [@r25]\]. Bacterial transmission among humans frequently occurs in confined environments, such as schools and households \[[@r6]\]; indeed, the spread of hemolytic uremic syndrome and bloody diarrhea caused by infection with a same clone of Shiga toxin-producing *Escherichia coli* has been reported in these environments \[[@r14], [@r18], [@r21]\]. Likewise, owners of companion animals could spread AR bacteria originating from their pets to other persons via close contact. However, there have been no studies investigating this possibility. We addressed this in the present study by comparing the genetic similarity of AR *E. coli* isolates from owners of dogs and non-owners sharing a classroom or household to determine the risk of secondary transmission of AR bacteria between humans.

MATERIALS AND METHODS {#s1}
=====================

Sampling
--------

All study participants provided written, informed consent for their participation. All protocols and procedures were approved by the institutional review board at the Seoul National University (IRB No. 1208/001-004). A total of 48 anal samples were collected from owners of dogs and non-owners at a college classroom and households located in Seoul, Korea, from April in 2010 to November in 2012. We used the sampling method described in previous studies \[[@r8], [@r15]\]. Owner samples (n=14) were collected from 11 undergraduate students as well as three of their family members; non-owner samples (n=34) were collected from 28 undergraduate students sharing the classroom with 11 owner students as well as six of their family members. Samples were placed in individual collection tubes containing Amies transport medium (Yu-Han Lab Tech, Seoul, Korea) and transported to our laboratory on ice within 6 hr of collection.

*E. coli* isolation and identification
--------------------------------------

For non-selective enrichment of microorganisms in samples, the swabs were mixed by vortexing in 10 m*l* buffered peptone water (BD Biosciences, Franklin Lakes, NJ, U.S.A.) and incubated at 37°C for 24 hr \[[@r31]\]. One milliliter aliquot of culture was inoculated in 9 m*lE. coli* broth and incubated at 37°C for 24 hr. The cultures were streaked on MacConkey agar plates and incubated at 37°C for 24 hr to isolate coliform bacteria, including *E. coli* \[[@r12]\]. Pink colonies suspected as *E. coli* were selected according to a standard protocol previously established in our laboratory \[[@r3]\]. Strain-specific PCR targeting 16S ribosomal RNA was carried out to confirm the bacterial species as *E. coli* \[[@r29]\]. *E. coli* ATCC 25922 (American Type Culture Collection, Manassas, VA, U.S.A.) was used as a positive control strain.

Antimicrobial susceptibility tests
----------------------------------

Antimicrobial susceptibility was tested by the standard disk diffusion method according to Clinical and Laboratory Standard Institute guidelines \[[@r35]\]. The antimicrobial disks (BD Biosciences) used in this study were as follows: ampicillin (AM, 10 *μ*g), amoxicillin/clavulanic acid (AMC, 20/10 *μ*g), aztreonam (ATM, 30 *μ*g), ceftazidime (CAZ, 30 *μ*g), cefotaxime (CTX, 30 *μ*g), cefotetan (CTT, 30 *μ*g), ceftriaxone (CRO, 30 *μ*g), chloramphenicol (30 *μ*g), ciprofloxacin (CIP, 5 *μ*g), imipenem (IMP, 10 *μ*g), gentamicin (GM, 10 *μ*g), nalidixic acid (NA, 30 *μ*g), sulfamethoxazole/trimethoprim (SXT, 1.25/23.75 *μ*g) and tetracycline (TE, 30 *μ*g). Resistance, intermediate resistance and susceptibility to antimicrobials were established as described by Clinical and Laboratory Standards Institute guidelines \[[@r35]\]. *E. coli* ATCC 25922 was used as a reference strain. Multidrug resistance (MDR) was defined as resistance to three or more different classes of antimicrobial \[[@r13]\].

Detection of integrase genes in *E. coli* isolates
--------------------------------------------------

To determine the association between MDR and the presence of mobile genetic elements, integrase genes responsible for horizontal gene transfer, were detected in all *E. coli* isolates. Briefly, the integrase genes were amplified by PCR using the common integrase primer set, *hep35* (5'-TGCGGGTYAARGATBTKGATTT-3') and *hep36* (5'-CARCACATGCGTRTARAT-3'). For positive isolates, PCR fragments were first digested with *HinfI* restriction enzyme (New England Biolabs, Ipswich, MA, U.S.A.) and analyzed by gel-electrophoresis. The class of integron was determined based on the number and size of DNA bands as previously described \[[@r34]\].

Molecular fingerprinting
------------------------

To investigate cross-transmission of AR *E. coli* between owners and non-owners, the genetic relatedness of AR *E. coli* isolates was evaluated by standard pulsed-field gel electrophoresis (PFGE) using CHEF MAPPER (Bio-Rad, Hercules, CA, U.S.A.) \[[@r10]\]. Briefly, isolates cultured overnight in tryptic soy broth (BD Biosciences) were streaked on tryptic soy agar (BD Biosciences) plates and incubated at 37°C for 14--18 hr. The turbidity of bacterial suspensions was adjusted to 4.0 McFarland, and cells were embedded in 1.0% agarose plugs that were lysed with proteinase K prepared as a 20 mg/m*l* stock solution (Sigma-Aldrich, St. Louis, MO, U.S.A.), followed by digestion for 2 hr with 50 U *Xba*I (New England Biolabs) at 37°C. Digested plugs were then placed on 1.0% SeaKem Gold agarose (Lonza, Allendale, NJ, U.S.A.), and PFGE was carried out at 6.0 V for 19 hr with a ramped pulse time of 6.76--35.38 sec in 0.5× Tris-Borate-EDTA buffer at 14°C. BioNumerics software (Applied Maths, Sint-Martens-Latem, Belgium) was used to analyze DNA restriction patterns using the dice coefficient (0.5% optimization and 1.0% tolerance) and the unweighted pair group method. *E. coli* ATCC 25922 was used as a reference strain.

RESULTS {#s2}
=======

Isolation of *E. coli* from swab samples
----------------------------------------

A total of 31 *E. coli* isolates were obtained from 48 swab samples (64.6%), with 9/14 (64.3%) and 22/34 (64.7%) collected from owners and non-owners, respectively ([Table 1](#tbl_001){ref-type="table"}Table 1.Antibiogram of 31 *E. coli* isolates from owners and non-ownersAntimicrobialNon-ownerOwnerTotal(n=22)(n=9)(n=31)AM13 (59.1)^a)^3 (33.3)16 (51.6)AMC11 (50.0)2 (22.2)13 (41.9)GM2 (9.1)1 (11.1)3 (9.7)TE11 (50.0)2 (22.2)13 (41.9)CIP4 (18.2)1 (11.1)5 (16.1)NA11 (50.0)4 (44.4)15 (48.4)SXT7 (31.8)2 (22.2)9 (29.0)C01 (11.1)1 (3.2)CRO1 (4.5)01 (3.2)CTX1 (4.5)01 (3.2)CAZ000CTT000IMP000ATM000MDR13 (59.1)3 (33.3)16 (51.6)AR ^b)^15 (68.2)5 (55.6)20 (64.5)a) Number of *E. coli* isolates showing resistance to each indicated antimicrobial is presented with the antimicrobial resistant rate in parenthesis. b) Antimicrobial resistant. This row shows the number of *E. coli* isolates showing resistance to at least one antimicrobial tested. AM, ampicillin; AMC, amoxicillin/clavulanic acid; ATM, aztreonam; C, chloramphenicol; CAZ, ceftazidime; CIP, ciprofloxacin; CRO, ceftriaxone; CTT, cefotetan; CTX, cefotaxime; GM, gentamicin; IMP, imipenem; MDR, multidrug resistance; NA, nalidixic acid; SXT, sulfamethoxazole/trimethoprim; TE, tetracycline.).

Antibiogram of 31 *E. coli* isolates
------------------------------------

The number of *E. coli* isolates showing resistance to each antimicrobial is shown in [Table 1](#tbl_001){ref-type="table"}. A total of 20/31 isolates (64.5%) from non-owners (n=15) and owners (n=5) were resistant to at least one antimicrobial ([Table 1](#tbl_001){ref-type="table"}). All isolates were susceptible to CAZ, CTT, IMP and ATM. The antibiogram analysis revealed frequencies of AR *E. coli* isolates of 51.6% (n=16) for AM followed by 48.4% (n=15) for NA, 41.9% (n=13 each) for AMC and TE, 29.0% (n=9) for SXT and 16.1% (n=5) for CIP. In addition, nine isolates showed resistance to each of GM, CRO and CTX. A total of 16 isolates (51.6%) were identified as harboring MDR *E. coli*.

Detection of integrase genes in *E. coli* isolates
--------------------------------------------------

Six of the 31 *E. coli* isolates (19.4%) harbored integrase genes ([Table 2](#tbl_002){ref-type="table"}Table 2.Characterization of six AR *E. coli* isolates harboring integrase genesIsolate no.Integron classSample groupAntibiogramIntegron-associated genes^a)^P99Class 1/*intI1*Non-owner (S)^b)^AM, AMC, TE, CIP, NA, SXT*OXA*, *tetB*, *dfrA17*P130-2Class 1/*intI1*Non-owner (S)AM, TE, SXT*OXA*, *tetA*, *dfrA7*P154-1Class 1/*intI1*Non-owner (S)AM, AMC, TE, CIP, NA, SXT*OXA*, *tetB*, *dfrA17*P150Class 1/*intI1*Non-owner (S)TE, NA, SXT*tetA*, *tetB*, *sul1*, *dfrA12/13*P143-1Class 1/*intI1*Owner (S)GM, TE, NA, SXT*tetB*, *sul1*, *dfrA17*P117-1Class 2/*intI2*Owner (F)AM, AMC, TE, SXT, C*OXA*, *tetB*, *sul1*, *dfrA1*, *cat1*a) *cat1*, chloramphenicol resistance gene; *dfrA1*/*A7*/*A17*/*A12/A13*, trimethoprim resistance genes; *OXA*, ampicillin resistance gene; *sul1*, sulfamethoxazole resistance gene; *tetA*/*B*, tetracycline resistance genes. b) S and F indicate college student and family member, respectively. AM, ampicillin; AMC, amoxicillin/clavulanic acid; C, chloramphenicol; CIP, ciprofloxacin; GM, gentamicin; NA, nalidixic acid; SXT sulfamethoxazole/trimethoprim; TE, tetracycline.). Of these, four originated from non-owners, and two were from owners. The four isolates from non-owners harbored only the class 1 integrase gene *intI1*, whereas both *intI1* and the class 2 integrase gene *intI2* were detected in the two isolates from owners. All six isolates were defined as having MDR, since they harbored at least three different antimicrobial resistance genes.

Genetic relatedness of *E. coli* isolates from owners and non-owners
--------------------------------------------------------------------

To determine the risk of cross-transmission between owners and non-owners, we analyzed the genetic relatedness of the 31 *E. coli* isolates by PFGE. Three clonal sets (PFGE types 5, 6 and 24) were identified ([Fig. 1A and 1B](#fig_001){ref-type="fig"}Fig. 1.PFGE analysis of 31 *E. coli* isolates. (A), Dendrogram of all PFGE patterns; (B), PFGE results of types 5, 6 and 24. Levels of similarity were determined using the Dice coefficient (0.5% optimization and 1.0% tolerance) and the unweighted pair-group method. Individual PFGE patterns are summarized with their antimicrobial resistance profiles and genes and sample sources (A). PFGE results of each isolate belonging to types 5, 6 and 24 are presented (B). AM, ampicillin; AMC, amoxicillin/clavulanic acid; C, chloramphenicol; CIP, ciprofloxacin; CRO, ceftriaxone; CTX, cefotaxime; GM, gentamicin; NA, nalidixic acid; SXT, sulfamethoxazole/trimethoprim; TE, tetracycline. a) Identification number of each *E. coli* isolate from pet owners and non-owners. b) Antimicrobial resistance profiles. c) Sample sources: college students (S) and family members (F). Students and family members living in the same house are represented by a combination of a letter and the same number, as follows: S1 (college student) and F1 (family member who lives in the same household as S1).). For type 5, two *E. coli* isolates (nos. P106-1 and P124) were obtained from two students (one non-owner and one owner) who shared a classroom, whereas the other isolate (no. P119) was from a family member of an owner student. For type 6, the three isolates (nos. P102, P103 and P99) were obtained from three non-owner students, but they had slightly different antibiogram profiles. For type 24, the two isolates (nos. P108 and P109) were from two non-owners living in the same household who showed identical antibiogram profiles.

DISCUSSION {#s3}
==========

AR bacteria can be cross-transmitted between humans and animals \[[@r7], [@r17]\]. Transmission is usually determined by detecting the same clonal isolates from different hosts \[[@r2]\]. Livestock (e.g., horse, goat and cattle) and wild animals (e.g., free-roaming elk) are sources of enteric pathogens and AR bacteria that can be transmitted to humans via direct or indirect contact \[[@r9]\]. Companion animals are also considered as sources of AR bacteria and infectious human pathogens \[[@r4], [@r7]\]. However, there is no direct evidence that AR bacteria originating from companion animals are cross-transmitted between owners and non-owners living in a confined community. Common enteric microorganisms, such as *E. coli*, are easily and inadvertently transferred between individuals via hand-to-hand contact \[[@r16]\]. In addition, *E. coli* isolated from feces is considered as a good indicator for antimicrobial resistance in a population \[[@r1], [@r5]\]. The current study was carried out in order to establish the risk of cross-transmission of AR bacteria originating from companion animals within a confined human community.

Of 31 *E. coli* isolates, 64.5% were identified as AR bacteria showing resistance to at least one antimicrobial. This rate is similar to that in healthy humans (67.1%), but much lower than that in human clinical specimens (98.5%) reported by a previous study from Korea \[[@r11]\]. Integrons are known to play an important role in the horizontal transfer of antimicrobial resistance genes by conjugative plasmids and transposons, and closely associated with the development of MDR in enterobacteria \[[@r22], [@r23]\]. Class I is the predominant class of integron detected in many countries including Korea \[[@r11], [@r19], [@r26]\]. Likewise, all integron positive *E. coli* isolates in this study were found to be multi-drug resistant, and the prevalent type was class I. PFGE analysis revealed that all isolates carrying integrons had distinct PFGE types ([Fig. 1A](#fig_001){ref-type="fig"}). This suggests that the dissemination of integrons was not due to clonal spread, but to horizontal gene transfer of plasmids or transposons, emphasizing the important role of integrons in the spread of antimicrobial resistance genes. The prevalence of integrons (19.4%) in *E. coli* isolates from healthy humans was higher than that reported in an earlier study from Korea \[[@r11]\], but lower than that in other countries \[[@r19], [@r30]\].

Three clonal sets were identified among 31 *E. coli* isolates, providing evidence of clonal expansion of resistant strains within the study population ([Fig. 1A and 1B](#fig_001){ref-type="fig"}). PFGE types 6 and 24 indicated the spreading of AR *E. coli* within a classroom and family, respectively, whereas PFGE type 5 included three isolates from a pet owner student, a non-owner student and an owner family member. Although we did not analyze *E. coli* isolates from the dogs in this study, our results indirectly demonstrate the possibility of cross-transmission of AR bacteria from companion animals to non-owners.

In most countries, the overall amount of antimicrobials used for companion animals is not reliably measured. However, antimicrobials used in human and veterinary hospitals are almost identical \[[@r7]\]; as such, resistance patterns in bacteria originating from animals and humans are very similar \[[@r28], [@r33]\]. There is an increasing concern that AR bacteria from pet animals can spread among humans. Although this study only investigated the clonal expansion of AR *E. coli* in a confined human community, the results indicate that once these bacteria are transmitted from pets to their owners, they can spread to other humans through social activities. Further investigations are required to provide more direct evidence and identify the risk factors of secondary transmission by studying larger numbers of bacterial isolates from pets, their owners and non-owners in a community.
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